483
Ajinomoto Althea, Inc.Ajinomoto Althea, Inc. – FDA 483, Sep 20, 2023
Record Details
Ajinomoto Althea, Inc. DBA Ajinomoto Bio-Pharma Services in San Diego, CA, was cited for significant deficiencies in microbial cross-contamination control and aseptic processing procedures. The inspection also found inadequate complaint investigations regarding particulate matter in finished drug products. These issues indicate a lack of robust quality control and adherence to sterile manufacturing practices.
View Company Profile
ID · 189c64ec-06f0-442c-9aaf-eb9ea48f6a0b
Other documents for Ajinomoto Althea, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.